Fundraising Fox

Steve Gillis

Investor

Managing Director at ARCH Venture Partners

Seattle, Washington

Writes $50K – $150M checks · typically $25M

About

Steve Gillis is an immunologist-turned-VC who founded Immunex and Corixa, helped develop Enbrel, and leverages roles at Takeda and early-stage biotech boards to bridge science and pharma operations.

LinkedIn ↗

Invests in

AI & Machine LearningBiotechDeep TechHardwareHealthtechMedical Devices

Experience

  1. ARCH Venture PartnersManaging Director

Shared employers

Also worked at ARCH Venture Partners25

Carol SuhPartner at ARCH Venture PartnersSean KendallPartner (Europe) at ARCH Venture PartnersCorey RitterPartner at ARCH Venture PartnersLuciana BorioVenture Partner at ARCH Venture PartnersJoseph JeongVenture Partner at ARCH Venture PartnersRichard HeymanVenture Partner at ARCH Venture Partners

+ 19 more

Deals · 2

Skylark Bio, Inc.Board seat

via ARCH Venture Partners · filed Apr 2024 · $40.9M raise

Skylark BioBoard seat

via ARCH Venture Partners · filed Aug 2022 · $34.9M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at ARCH Venture Partners

Ari Nowacek
Partner at ARCH Venture Partners
Axel Bouchon
Venture Partner at ARCH Venture Partners
Brian Cuneo
Senior Partner at ARCH Venture Partners
Carol Suh
Partner at ARCH Venture Partners
Clinton Bybee
Co-founder & Managing Director, Emeritus at ARCH Venture Partners
Corey Ritter
Partner at ARCH Venture Partners
David Moore
Senior Partner at ARCH Venture Partners
George Scangos
Venture Partner at ARCH Venture Partners

Network1

Dave Maki
Managing Partner at Altitude Ventures Management, Llc

Investors connected to Steve in public investor directories — a warm-intro map.